Advancing excellence in laboratory medicine for better healthcare worldwide

Tool kit - 11) Ethics and Industry

2019

Kanter GP, Carpenter D, Lehmann L, Mello MM.Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment. BMJ Open. 2019;9(2):e024020.

Hopkins B, Yamaguchi JT, Cloney MB, Shlobin NA, Dahdaleh NS. Effects of the physician payments sunshine act on the patient experience and perception of care amongst neurosurgeons: A comparative study of online PRW ratings and industry payments. Clin Neurol Neurosurg. 2019;176:127-132.

Garstka ME, Monlezun D, DuCoin C, Killackey M, Kandil E.The Sunshine Act and Surgeons: A Nation-Wide Analysis of Industry Payments to Physicians. J Surg Res. 2019;233:41-49.

Brunt CS. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act. Health Serv Res. 2019;54(3):636-649.

2018

DeCensi A, Numico G, Ballatori E, Artioli F, Clerico M, Fioretto L, et al. Conflict of interest among Italian medical oncologists: a national survey. BMJ Open. 2018;8(6):e020912.

Jaiswal D, Checketts JX, Vassar M. Industry Payments in Cardiology: A Cross-sectional Analysis of Open Payments Data.J Am Osteopath Assoc. 2018;118(12):781-787.

2017

Pham-Kanter G, Mello MM, Lehmann LS, Campbell EG, Carpenter D. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.J Gen Intern Med. 2017;32(7):767-774.

Saver RS.Deciphering the Sunshine Act: Transparency Regulation and Financial Conflicts in Health Care. Am J Law Med. 2017;43(4):303-343.

Bandari J, Ayyash OM, Turner RM 2nd, Jacobs BL, Davies BJ.The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide. Cancer. 2017;123(22):4356-4362.

Sinha MS, Kesselheim AS.The Effects of the Sunshine Act: What Can and Should We Expect?. Am J Bioeth. 2017;17(6):22-24.

2016

Smilowitz NR, Pirmohamed A, Weisz G.Published Articles Reporting Studies by Industry Employees on Interventional Cardiology Devices: Scope and Association With Study Outcomes.JAMA Intern Med. 2016;176(5):706-8.

Marshall DC, Jackson M, Hattangadi-Gluth JA.Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program. Mayo Clin Proc. 2016;91(1):84-96.

2015

Cvetanovich GL, Chalmers PN, Bach BR Jr.Industry Financial Relationships in Orthopaedic Surgery: Analysis of the Sunshine Act Open Payments Database and Comparison with Other Surgical Subspecialties. J Bone Joint Surg Am. 2015;97(15):1288-95.

Harvey HB, Alkasab TK, Pandharipande PV, Halpern EF, Prabhakar AM,Oklu R, et al.Non-Research-Related Physician-Industry Relationships of Radiologists in the United States.J Am Coll Radiol. 2015;12(11):1142-50.

Toroser D, DeTora L, Cairns A, Juneja R, Georgieva A, Weigel A, Pepitone K.The sunshine act and medical publications: Guidance from professional medical associations. Postgrad Med. 2015;127(7):752-7.

2014

Dickerson DM, Naidu RK. Preparing for the physician payment sunshine act. Reg Anesth Pain Med. 2014;39(3):185-8.

2013

Agrawal S, Brennan N, Budetti P.The Sunshine Act--effects on physicians.N Engl J Med. 2013;368(22):2054-7.

2012

Grundy Q. The Physician Payments Sunshine Act and the unaddressed role of nurses: an interest group analysis.Policy Polit Nurs Pract. 2012;13(3):154-61.

2010

Campbell EG, Rao SR, DesRoches CM, Iezzoni LI, Vogeli C, Bolcic-Jankovic D, Miralles PD.Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Arch Intern Med. 2010;170(20):1820-6.

Appelbaum PS, Gold A.Psychiatrists' relationships with industry: the principal-agent problem. Harv Rev Psychiatry. 2010;18(5):255-65.

Bruguera CM, Hirsch JA. Letting the sunshine in: shining a new light on physician-industry relationships.J Neurointerv Surg. 2010;2(1):80-2.

Grande D. Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention? J Gen Intern Med. 2010;25(1):79-83.

Miyata Y.[Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education]. [Article in Japanese]. Seishin Shinkeigaku Zasshi. 2010;112(11):1136-45.

2007

Grande D. A national survey of physician-industry relationships. N Engl J Med. 2007;357(5):507-8

Gorske AL.A national survey of physician-industry relationships. N Engl J Med. 2007;357(5):508

Sade RM. A national survey of physician-industry relationships. N Engl J Med. 2007;357(5):507

2005

Grant DC, Iserson KV. Who's buying lunch: are gifts to surgeons from industry bad for patients?. Thorac Surg Clin. 2005;15(4):533-42.

Witkowski P, Liu JW, Jin MX, Liu Z, Suciu-Foca N, Hardy MA. Infectious tolerance mediated by CD8+ T-suppresor cells after UV-B-irradiated donor-specific transfusion and rat heart transplantation.Transplant Proc. 2005;37(1):43-5.

Breckenridge A, Woods K. Medicines regulation and the pharmaceutical industry. BMJ. 2005; 331(7520):834-6.

2003

Epps CH Jr. Ethical guidelines for orthopaedists and industry. Clin Orthop Relat Res. 2003;(412):14-20.

2000

Weihrauch TR. [Career opportunities for female and male physicians in the pharmaceutical industry].[Article in German]. Med Klin (Munich). 2000;95(6):322-6.

 

 
Website developed by Insoft